iSERA Lifesciences Reports Q2FY27 Standalone Net Loss of ₹13.11 Lakhs
iSERA Lifesciences Ltd · Financial Result · 05 Nov 2026, 3:01 am
iSERA Lifesciences Reports Q2FY27 Standalone Net Loss of ₹13.11 Lakhs iSERA Lifesciences reported standalone net loss of ₹13.11 lakhs for the quarter ended 30th Sep'26, narrowing QoQ from a loss of ₹33.62 lakhs in Jun'26, compared to a profit of ₹0.70 lakhs in 30th Sep'25. Revenue from operations remained nil, while other income stood at ₹7.88 lakhs. Total expenses were ₹20.99 lakhs versus ₹33.62 lakhs in the prior quarter. For H1FY27, net loss widened to ₹46.73 lakhs from ₹0.84 lakhs YoY. Basic and diluted EPS for the quarter was negative ₹0.62.
Original exchange filing (PDF)
More announcements from iSERA Lifesciences Ltd
- Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Administrative Warning Letter received .... · 15 Nov 2026
- Dissemination of Warning Letter of SEBI · 12 Nov 2026
- We hereby submit that pursuant to Regulation 15(2) of SEBI (LODR) Regulations, 2015, the compliance with the corporate governance provisions as specified in Regulations 17, 18, 19, 20, .... · 04 Nov 2026
- We hereby submit the Un-Audited Financial Result for the quarter and half yearly ended September 2026 · 04 Nov 2026
- Outcome of the Board Meeting held today on 4th November 2026 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 04 Nov 2026
- Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Un-Audited Financial .... · 04 Nov 2026
- Disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Continual Disclosure consequent to Preferential Allotment of .... · 09 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Archana Lonkar · 07 Oct 2026
